Suppr超能文献

迁移增强因子:一种新的淋巴因子。

Migration enhancement factor: a new lymphokine.

作者信息

Weisbart R H, Bluestone R, Goldberg L S, Pearson C M

出版信息

Proc Natl Acad Sci U S A. 1974 Mar;71(3):875-9. doi: 10.1073/pnas.71.3.875.

Abstract

Production of human migration inhibitory factor by lymphocytes exposed to antigen was studied at intervals over a 7-day period. Migration inhibitory factor was measured by an agarose gel method, with buffycoat leukocytes as indicator cells. Lymphocyte supernatants from 7-day cultures consistently showed migration inhibitory factor activity; by contrast, enhancement of migration was frequently noted when effector cells were exposed to supernatants from 2- to 5-day cultures. Enhancement activity was manifested either by enhanced migration or by a sequential reduction in inhibitory activity consistent with a factor opposing the action of migration inhibitory factor. When supernatants were subjected to polyacrylamide gel electrophoresis, enhancement activity was regularly found in the beta-globulin region and migration inhibitory factor in the albumin fraction of the gel. The enhancement activity was heat-stable and nondialyzable. These findings characterize a hitherto unreported lymphokine, migration enhancement factor.

摘要

在7天的时间内,定期研究暴露于抗原的淋巴细胞产生人迁移抑制因子的情况。迁移抑制因子采用琼脂糖凝胶法,以血沉棕黄层白细胞作为指示细胞进行测定。来自7天培养物的淋巴细胞上清液始终显示出迁移抑制因子活性;相比之下,当效应细胞暴露于2至5天培养物的上清液时,经常会观察到迁移增强现象。增强活性表现为迁移增强或抑制活性的顺序降低,这与一种对抗迁移抑制因子作用的因子一致。当对上清液进行聚丙烯酰胺凝胶电泳时,增强活性通常出现在凝胶的β球蛋白区域,而迁移抑制因子出现在白蛋白部分。增强活性是热稳定的且不可透析。这些发现表征了一种迄今未报道的淋巴因子,即迁移增强因子。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f36/388118/44066f5178ab/pnas00056-0291-a.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验